Analyst Price Targets — BRKR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 2:44 pm | Evie Koslosky | Goldman Sachs | $35.00 | $37.19 | TheFly | Bruker price target lowered to $35 from $40 at Goldman Sachs |
| February 13, 2026 2:33 pm | — | UBS | $49.00 | $36.99 | TheFly | Bruker price target raised to $49 from $43 at UBS |
| February 13, 2026 11:09 am | Luke Sergott | Barclays | $50.00 | $37.51 | TheFly | Bruker price target lowered to $50 from $55 at Barclays |
| February 12, 2026 7:24 pm | — | Jefferies | $50.00 | $37.51 | TheFly | Bruker price target lowered to $50 from $55 at Jefferies |
| January 26, 2026 2:35 pm | — | Guggenheim | $58.00 | $49.03 | TheFly | Bruker price target raised to $58 from $53 at Guggenheim |
| January 5, 2026 2:26 pm | Subbu Nambi | Guggenheim | $53.00 | $49.87 | TheFly | Bruker price target raised to $53 from $45 at Guggenheim |
| December 15, 2025 11:27 am | Brandon Couillard | Wells Fargo | $55.00 | $45.13 | TheFly | Bruker price target raised to $55 from $48 at Wells Fargo |
| December 15, 2025 10:54 am | — | Barclays | $55.00 | $45.13 | TheFly | Bruker price target raised to $55 from $45 at Barclays |
| December 10, 2025 1:53 pm | — | Wolfe Research | $60.00 | $47.65 | TheFly | Wolfe upgrades Bruker to Outperform on 2026 growth |
| December 9, 2025 9:29 am | — | Goldman Sachs | $40.00 | $46.00 | TheFly | Bruker initiated with a Sell at Goldman Sachs |
Latest News for BRKR
On April 17, 2026, Bruker Corp (BRKR) shares rose 4.5% today, bringing the current price to $40.70. The stock has experienced a 52-week range of $28.53 to $56.2
SAN DIEGO--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced new updates from Bruker Spatial Biology to be showcased at the 2026 American Association for Cancer Research (AACR) Annual Meeting. At AACR, Bruker Spatial Biology will highlight how its high-fidelity spatial platforms—designed to work together—deliver deeper insights into oncology biology and accelerate translational…
MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division (Bruker Corporation, Nasdaq: BRKR) announces the European launch of MyGenius PRO®, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology. Designed for infectious disease diagnostics, the new S2A system enables higher throughput,…
MUNICH--(BUSINESS WIRE)---- $BRKR #BRKR--At ESCMID Global 2026, Bruker announces important portfolio enhancements across microbial identification, outbreak analysis, and reflex next‑generation sequencing (NGS) typing. These latest developments underscore Bruker's continued commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges.…
ASILOMAR, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--At the Experimental Nuclear Magnetic Resonance Conference (ENC), Bruker Corporation (Nasdaq: BRKR) today announced new NMR products and workflow solutions designed to expand performance, sensitivity, and automation across research and applied NMR. The introductions span console electronics, quantitative chemistry, benchtop FT-NMR, solid-state and dissolution Dynamic…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.